Search ARM

Allarta is an emerging cell therapy company with platform technology to build allogeneic cell-based therapies for metabolic disorders, inflammatory disorders, and oncology. Allarta’s proprietary immune-evasive materials are based on 30+ years of foundational science. Our lead product is a therapeutic for T1D, consisting of donor and stem cell-derived insulin-producing cells embedded in immune-protective hydrogels to avoid the need for immune suppression. Allarta is currently in large animal studies with a clear path to the clinic.

Contact Allarta Life Science Inc
Visit Website